BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• BioMidwest

  DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia

  DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.

  June 26, 2024

   · 

  13 min read
• Biotech Beach

  Scale Biosciences Announces ScalePlex Technology to Simplify Single Cell Genomics Studies of Any Scale

  Scale Biosciences announced the availability of ScalePlex an advanced single cell multiplexing technology designed to simplify large-scale single cell genomics studies.

  June 26, 2024

   · 

  3 min read
• BioMidwest

  First patient enrolled in landmark clinical study to assess 3D printed models for orthopedic tumor removal

  Ricoh USA, Inc. and Stratasys Ltd. (NASDAQ: SSYS) today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.

  June 26, 2024

   · 

  5 min read
• FDA

  Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

  Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application and granted Fast Track designatio.

  June 26, 2024

   · 

  7 min read
• BioMidwest

  First Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal

  Stratasys Ltd. and Ricoh USA, Inc. announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology.

  June 26, 2024

   · 

  5 min read
• BioMidwest

  Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

  Aclarion, Inc. announced their initial payer coverage of Nociscan by AXA in London, UK in conjunction with The London Clinic, one of the UK’s largest and most renowned independent hospitals.

  June 26, 2024

   · 

  4 min read
• BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study

  BioStem Technologies Inc. today announced that an article validating its proprietary processing method and its placental allograft products has been published in the international, peer-reviewed journal, Health Science Reports.

  June 26, 2024

   · 

  5 min read
• Korea University Identifies Novel Inhibitor HVH-2930 Showing Promise in Overcoming Trastuzumab Resistance in HER2-Positive Breast Cancer

  Korean scientists have investigated HVH-2930, an innovative HSP90 inhibitor in reshaping HER2-positive breast cancer treatment.

  June 26, 2024

   · 

  3 min read
• Business

  Medtronic announces departure of Karen Parkhill, Chief Financial Officer

  Medtronic plc today announced that Karen Parkhill will resign as executive vice president and chief financial officer to accept the role of chief financial officer for HP Inc.

  June 26, 2024

   · 

  3 min read
• Lone Star Bio

  Pillar Clinical Research Expands Leadership Team with the Addition of Zach Mitchell as Chief Commercial Officer

  Pillar Clinical Research, a multi-specialty clinical research site network, has announced the appointment of Zach Mitchell as Chief Commercial Officer.

  June 26, 2024

   · 

  2 min read